Urology

Latest Ask the Experts

Biomarker Assays for Prostate Cancer Management

Should biomarker assays be an integral part of prostate cancer patient care?

Urology News

Latest Urology News

Prostate Cancer Prostate Biopsy Complications Deter Patients From Re-Biopsy

Prostate Biopsy Complications Deter Patients From Re-Biopsy

Study participants with acute urinary retention after TRUS-guided prostate biopsy were 4.5 times more likely to skip a recommended re-biopsy than men who had no initial biopsy-related complications.

Urology Peri-Op RBC Transfusions Linked to Postoperative VTE

Peri-Op RBC Transfusions Linked to Postoperative VTE

Perioperative red blood cell transfusion linked to increased adjusted odds of VTE, DVT, PE.

Benign Prostatic Hyperplasia (BPH) Study: Non-Bothering Nocturia Worth Treating

Study: Non-Bothering Nocturia Worth Treating

Over 12 weeks of treatment, the mean number of nocturia episodes decreased by 1.1 and 0.9 in men who were and were not bothered by their symptoms, a non-significant difference between groups.

Prostate Cancer Long-Term Data Support Finasteride for PCa Prevention

Long-Term Data Support Finasteride for PCa Prevention

Clinicians can rest easier about recommending finasteride to more men, according to experts.

Erectile Dysfunction (ED) Erectile Dysfunction Strongly Predicts Cardiovascular Events

Erectile Dysfunction Strongly Predicts Cardiovascular Events

Men with erectile dysfunction (ED) are almost twice as likely to experience a cardiovascular event as those without ED.

Prostate Cancer Prostate Cancer Treatment Side Effects Linked to Distress

Prostate Cancer Treatment Side Effects Linked to Distress

Those with worse emotional distress also report worse urinary, sexual, bowel functions.

Prostate Cancer Biparametric MRI Improves Detection of Significant PCa

Biparametric MRI Improves Detection of Significant PCa

If externally validated, bpMRI could be used to triage men for prostate biopsy.

Urology FDA OKs 1st Biosimilar to Prevent Chemo-Related Infections

FDA OKs 1st Biosimilar to Prevent Chemo-Related Infections

Fulphila, biosimilar to Neulasta, helps reduce risk of infection during cancer treatment.

Prostate Cancer Abiraterone for mCRPC May Benefit Blacks More Than Whites

Abiraterone for mCRPC May Benefit Blacks More Than Whites

Abiraterone plus prednisone was associated with significantly greater PSA progression-free survival among patients who are black compared with white patients.

Prostate Cancer Enzalutamide for Advanced Prostate Cancer Does Not Worsen HRQoL

Enzalutamide for Advanced Prostate Cancer Does Not Worsen HRQoL

Enzalutamide decreases the risk of clinically meaningful deterioration in HRQoL compared with placebo in men with non-metastatic CRPC, new study finds.

Urology ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care

ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care

98.4% of respondents report moderate, severe shortages of morphine, hydromorphone, fentanyl.

Kidney Cancer Sunitinib Alone or After Surgery for mRCC Offers Similar Outcomes

Sunitinib Alone or After Surgery for mRCC Offers Similar Outcomes

New findings from the CARMENA trial contradict previous research showing better survival from cytoreductive nephrectomy followed by targeted therapy.

Urinary Incontinence Yoga Can Reduce Urinary Incontinence in Older Women

Yoga Can Reduce Urinary Incontinence in Older Women

Greater decrease in total UI frequency with yoga intervention versus time-and-attention control group.

Urology Reduced-Dose Anticoagulants Feasible for Extended VTE Tx

Reduced-Dose Anticoagulants Feasible for Extended VTE Tx

May be as effective as full-dose direct oral anticoagulants for extended-duration treatment.

Prostate Cancer AUA Updates Castration-Resistant Prostate Cancer Clinical Guideline

AUA Updates Castration-Resistant Prostate Cancer Clinical Guideline

"We are confident this guideline is fully aligned with the latest science on treatments for patients with non-metastatic and metastatic CRPC," said Michael Cookson, MD, member of the 2018 amendment panel.

Urology Senior Cancer Patients Also Benefit From Palliative Radiotherapy

Senior Cancer Patients Also Benefit From Palliative Radiotherapy

Benefit of palliative radiation for bone metastasis across age groups; older age should not preclude tx.

Prostate Cancer PSA Level 3 Months After Radiation Tx May Predict Outcome

PSA Level 3 Months After Radiation Tx May Predict Outcome

Findings for men with intermediate- and high-risk prostate cancer.

Urology Rivaroxaban Linked to Low VTE Recurrence in Active Cancer

Rivaroxaban Linked to Low VTE Recurrence in Active Cancer

Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin.

Prostate Cancer Current Smokers at Risk for Worse Prostate Cancer Outcomes

Current Smokers at Risk for Worse Prostate Cancer Outcomes

In a meta-analysis, smokers had an 89% greater risk of dying from prostate cancer compared with nonsmokers.

Prostate Cancer FDA Approves Yonsa for Metastatic Castration-Resistant Prostate Cancer

FDA Approves Yonsa for Metastatic Castration-Resistant Prostate Cancer

The approval of Yonsa was based on 2 randomized, placebo-controlled, multicenter Phase 3 studies in patients with mCRPC.